KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $66.5 billion.

  • Bristol Myers Squibb's Total Non-Current Liabilities fell 732.58% to $66.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $66.5 billion, marking a year-over-year decrease of 732.58%. This contributed to the annual value of $66.5 billion for FY2025, which is 732.58% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Total Non-Current Liabilities stood at $66.5 billion for Q4 2025, which was down 732.58% from $72.8 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Total Non-Current Liabilities registered a high of $75.8 billion during Q1 2024, and its lowest value of $55.6 billion during Q2 2023.
  • Its 5-year average for Total Non-Current Liabilities is $65.5 billion, with a median of $66.3 billion in 2021.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 1302.9% in 2023, then soared by 3592.26% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Total Non-Current Liabilities stood at $66.0 billion in 2021, then dropped by 10.4% to $59.1 billion in 2022, then increased by 0.24% to $59.3 billion in 2023, then increased by 21.08% to $71.7 billion in 2024, then fell by 7.33% to $66.5 billion in 2025.
  • Its last three reported values are $66.5 billion in Q4 2025, $72.8 billion for Q3 2025, and $72.2 billion during Q2 2025.